对罕见疾病的贝叶斯适应性可行性设计
Maureen M Churipuy1, Shirin Golchi1, Marie Hudson2
1Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.
Contemporary clinical trials communications
|December 2, 2024
概括
本研究引入了贝叶斯设计,使用试点数据来预测临床试验样本大小可行性. 这种方法提高了效率,特别是在罕见疾病试验中.
科学领域:
- 临床试验 临床试验
- 生物统计学 生物统计学
- 贝叶斯的方法 贝叶斯的方法
背景情况:
- 在研究开始之前,评估临床试验可行性,特别是样本大小的实现,至关重要.
- 传统方法可能无法充分预测复杂试验的样本大小成功.
研究的目的:
- 提出一个新的贝叶斯设计,用于预测临床试验样本大小可行性.
- 为了证明这种设计在规划III期试验中的实用性,特别是对于罕见疾病.
主要方法:
- 提出了一个贝叶斯框架,利用试点研究数据.
- 一个基于玛-波桑分布的预测模型概述了估计目标样本大小.
- 该设计使用模拟研究来说明在轻度系统性硬化症的III期试验的设计.
主要成果:
- 建议的贝叶斯设计有效地预测了样本大小的可行性.
- 玛-鱼分布模型为样本大小预测提供了一个强大的方法.
- 预测性设计显示了提高罕见疾病临床试验效率的巨大潜力.
结论:
- 提出的贝叶斯设计为改善临床试验规划和可行性评估提供了有价值的工具.
- 这种方法可以导致更有效和成功的罕见疾病临床试验.
- 准确的样本大小预测是优化资源配置和试验结果的关键.
相关概念视频
Kaplan-Meier Approach
98
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
98
Assumptions of Survival Analysis
97
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
97
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
120
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
120
Probability Laws
40.1K
Overview
40.1K
Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K
Comparing the Survival Analysis of Two or More Groups
150
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
150


